Tempest Therapeutics Stock Pattern Recognition Ladder Bottom

TPST Stock

USD 2.26 -0.03 -1.31%

The pattern recognition view organizes Ladder Bottom recognition and supporting indicators around Tempest Therapeutics. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. The Ladder Bottom is a reversal pattern describing Tempest Therapeutics bullish trend.

Tempest Therapeutics Technical Analysis Modules

Most technical analysis of Tempest Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tempest from various momentum indicators to cycle indicators. When you analyze Tempest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc. Tempest Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people. Liquidity and trading activity can influence how quickly new information is reflected in Tempest Therapeutics's price. Lower trading activity may introduce occasional variability in execution conditions. Tempest Therapeutics has a market cap of 30.87 M, P/E of 0.23, ROE of -4.05%.

Methodology

Unless otherwise specified, financial data for Tempest Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tempest (USA Stocks:TPST) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Tempest Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Tempest Therapeutics is covered by 1 analyst. Representative analyst firms may include RBC Capital Markets, Barclays, HSBC Global Research, Wells Fargo Securities, Bank of America Securities, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Learn to be your own money manager

Tracking Tempest Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Did you try this?

Run Portfolio File Import Now

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format

All Next

Launch Module

Tempest Therapeutics pair trading

Pair trading with Tempest Therapeutics can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Tempest Therapeutics Pair Trading

Tempest Therapeutics Pair Trading Analysis

Pair-trading logic also applies to tax-loss harvesting: by identifying an asset with near-identical factor exposures to Tempest Therapeutics, investors can effectively maintain a synthetic Tempest Therapeutics position while the wash-sale clock resets.

The correlation structure around Tempest Therapeutics evolves as market regimes change. Assets that were once uncorrelated with Tempest Therapeutics may become correlated during crises, so investors should monitor rolling correlations alongside static long-run averages.

Pair evaluation and Correlation analysis for Tempest Therapeutics provide hedging context. The approach can be applied within sectors or across broader universes.

Pair Correlation Correlation Matching

Additional Tools for Tempest Stock Analysis

	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC